Bionic pancreas approved by FDA 16 June 2023 Image courtesy of betabionics.com In recent weeks the US Food and Drugs Administration (FDA) has approved Beta Bionics for use by people over 6 years of age living with type 1 diabetes in the US. When paired with the Dexcom G6 continuous glucose monitor, the pocket-sized device can deliver tailored insulin doses every five minutes, based on calculations of current and past glucose levels and the body鈥檚 reaction to previous insulin deliveries. Where a standard insulin pump must be adjusted manually based on what the user estimates the carbohydrate count of their meal to be, the bionic pancreas adjusts insulin levels internally through communication with the Dexcom G6. This allows blood glucose levels to be regulated with minimal input from the user. At set up, all that is needed is for the wearer to enter their weight and following that the only interaction needed is to input an estimation of whether a meal is low, medium, or high in carbohydrates. In the iLET Bionic Pancreas was found to be effective in聽keeping blood glucose levels in target range for 11% longer than when participants were using their usual diabetes technology.聽The device was also found to reduce聽HbA1c levels across all the participant groups, regardless of their ethnic background, education, or income level.聽 Beta Bionics says the device provides more flexibility in type 1 diabetes management and takes away the constant measuring of blood glucose levels and calculations for insulin doses that so many living with type 1 diabetes have to do each day. The approval by the FDA in the US is a huge milestone in a two-decade journey for Ed Damiano who was inspired to develop the system after his son was diagnosed with diabetes when he was just 11 months old. 鈥淭his milestone is particularly poignant to me as the news of FDA clearance coincided with the 24th birthday of my son, David, who developed type 1 diabetes as an infant, just over 23 years ago,鈥� Damiano, founder and executive chairman at Beta Bionics, told Boston University鈥檚 The Brink. The iLET Bionic Pancreas is currently only available in the US.
Media releases 17 August 2026 芒果直播 to deliver Insulin Pump Program supporting children and young people 芒果直播 has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading
Blog 29 July 2026 Act F.A.S.T. on stroke People with diabetes have a higher risk of stroke. Know the F.A.S.T. signs and work with your healthcare team to reduce risk Continue Reading
News 20 July 2026 Response to media reports from 60 Minutes, The Sydney Morning Herald, and The Age regarding regulation of diabetes technologies The safety of people living with diabetes must always come first. For many Australians, technologies such as insulin pumps and continuous glucose monitors are essential tools that help prevent dangerous high and low blood glucose levels, reduce the daily burden of living with diabetes and improve long-term health outcomes. For some individuals they can be life-changing or even life-saving. Continue Reading
